Blood type association with bleeding outcomes at delivery in a large multi-center study

J Thromb Thrombolysis. 2020 Aug;50(2):439-445. doi: 10.1007/s11239-019-02023-4.

Abstract

Postpartum hemorrhage is a leading cause of maternal death globally. Recent studies have associated Type-O group to increased risk of bleeding. We aimed to determine if women with Type-O blood are at higher risk of PPH. This is a retrospective cohort analysis of a multi-center database included women admitted to labor and delivery from January 2015 to June 2018. All deliveries resulting in live birth were included. Association between Type-O and non Type-O were examined using chi-square test and fishers exact test. Prevalence of postpartum hemorrhage, estimated blood loss, drop in hematocrit and red blood cell transfusion were compared. The matched sample included 40,964 Type-O and the same number of no Type-O. The overall prevalence of postpartum hemorrhage was 6.4%, and there was no difference in the prevalence of PPH among Type-O compared to non Type-O (6.38% vs. 6.37% respectively; p = 0.96). There was no difference in hematocrit drop and estimated blood loss between Type-O and non Type-O in all deliveries. However, in cesarean delivery there was a significant difference in blood loss among the two groups. Finally, Type-O had 1.09-fold increased risk for transfusion compared to non Type O (95% CI 0.9-1.34). There is an association between Type-O group and risk of bleeding in women undergoing cesarean delivery. More prospective studies, taking into account coagulation profile, platelet count and tissue factors, are needed to draw a conclusion on whether ABO system can be considered a heritable risk of postpartum hemorrhage.

Keywords: ABO; Blood group; Postpartum hemorrhage; Von Willebrand disease.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • ABO Blood-Group System*
  • Adult
  • Cesarean Section / adverse effects
  • Cesarean Section / mortality
  • Databases, Factual
  • Erythrocyte Transfusion
  • Extraction, Obstetrical / adverse effects
  • Extraction, Obstetrical / mortality
  • Female
  • Hematocrit
  • Humans
  • Maternal Mortality
  • Postpartum Hemorrhage / blood*
  • Postpartum Hemorrhage / diagnosis
  • Postpartum Hemorrhage / mortality
  • Postpartum Hemorrhage / therapy
  • Pregnancy
  • Prevalence
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • United States / epidemiology
  • Young Adult

Substances

  • ABO Blood-Group System